Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hnf1a
|
ENSMUSG00000029556.6 | HNF1 homeobox A |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr5_114971271_114971424 | Hnf1a | 253 | 0.786248 | 0.81 | 4.9e-15 | Click! |
chr5_114970896_114971201 | Hnf1a | 19 | 0.925704 | 0.75 | 5.3e-12 | Click! |
chr5_114972239_114972459 | Hnf1a | 1255 | 0.229677 | 0.59 | 5.7e-07 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr5_114969022_114970855 | 23.54 |
Hnf1aos1 |
HNF1 homeobox A, opposite strand 1 |
18 |
0.91 |
chr1_125676834_125678312 | 11.33 |
Gpr39 |
G protein-coupled receptor 39 |
578 |
0.8 |
chr7_138538151_138538399 | 9.38 |
4930543N07Rik |
RIKEN cDNA 4930543N07 gene |
15955 |
0.26 |
chr3_98892875_98893298 | 9.30 |
Hao2 |
hydroxyacid oxidase 2 |
153 |
0.94 |
chr18_75384437_75388058 | 8.35 |
Smad7 |
SMAD family member 7 |
11333 |
0.21 |
chr6_99275359_99276069 | 7.08 |
Foxp1 |
forkhead box P1 |
9182 |
0.29 |
chr18_66503913_66504586 | 7.06 |
Gm9926 |
predicted gene 9926 |
68 |
0.95 |
chr11_98446534_98448432 | 6.97 |
Grb7 |
growth factor receptor bound protein 7 |
415 |
0.68 |
chr10_115817324_115818606 | 6.70 |
Tspan8 |
tetraspanin 8 |
681 |
0.78 |
chr8_53614057_53614328 | 6.66 |
Neil3 |
nei like 3 (E. coli) |
1628 |
0.5 |
chr6_143750987_143751675 | 6.45 |
1700060C16Rik |
RIKEN cDNA 1700060C16 gene |
100043 |
0.08 |
chr10_69321361_69322099 | 6.31 |
Gm40685 |
predicted gene, 40685 |
9591 |
0.17 |
chr19_43711597_43711748 | 5.70 |
Entpd7 |
ectonucleoside triphosphate diphosphohydrolase 7 |
260 |
0.88 |
chr5_24426725_24429282 | 5.66 |
Slc4a2 |
solute carrier family 4 (anion exchanger), member 2 |
205 |
0.83 |
chr19_56287823_56288746 | 5.65 |
Habp2 |
hyaluronic acid binding protein 2 |
288 |
0.91 |
chr11_119393968_119394119 | 5.58 |
Rnf213 |
ring finger protein 213 |
943 |
0.46 |
chr5_96521474_96521929 | 5.31 |
Gm42605 |
predicted gene 42605 |
35935 |
0.18 |
chr17_70856938_70857408 | 5.30 |
Gm9320 |
predicted gene 9320 |
3406 |
0.12 |
chr4_44633883_44634171 | 5.25 |
Pax5 |
paired box 5 |
11696 |
0.15 |
chr10_34483356_34484742 | 5.21 |
Frk |
fyn-related kinase |
517 |
0.83 |
chr15_12193885_12195324 | 5.18 |
Gm49240 |
predicted gene, 49240 |
2015 |
0.19 |
chr7_30493583_30494737 | 5.14 |
Prodh2 |
proline dehydrogenase (oxidase) 2 |
380 |
0.63 |
chr1_172501767_172503923 | 5.03 |
Tagln2 |
transgelin 2 |
1593 |
0.22 |
chr14_51096211_51096662 | 4.95 |
Rnase4 |
ribonuclease, RNase A family 4 |
77 |
0.83 |
chr10_77221484_77221675 | 4.95 |
Pofut2 |
protein O-fucosyltransferase 2 |
37639 |
0.13 |
chr16_20908673_20909057 | 4.84 |
Gm49742 |
predicted gene, 49742 |
15306 |
0.14 |
chr1_135820977_135821380 | 4.80 |
Lad1 |
ladinin |
2580 |
0.2 |
chr5_123975536_123976239 | 4.67 |
Hip1r |
huntingtin interacting protein 1 related |
2259 |
0.17 |
chr8_68016310_68016461 | 4.64 |
Gm22018 |
predicted gene, 22018 |
6045 |
0.25 |
chr2_29750670_29752031 | 4.58 |
Gm13420 |
predicted gene 13420 |
335 |
0.8 |
chr13_42367794_42368043 | 4.55 |
Gm47118 |
predicted gene, 47118 |
62927 |
0.12 |
chr3_129223881_129225649 | 4.55 |
Gm43697 |
predicted gene 43697 |
763 |
0.61 |
chr13_23687940_23688389 | 4.53 |
H2bc4 |
H2B clustered histone 4 |
3965 |
0.06 |
chr5_64813848_64814093 | 4.31 |
Klf3 |
Kruppel-like factor 3 (basic) |
1586 |
0.32 |
chr2_65171540_65171753 | 4.19 |
Cobll1 |
Cobl-like 1 |
64349 |
0.11 |
chr2_164221704_164221855 | 4.18 |
Wfdc15b |
WAP four-disulfide core domain 15B |
119 |
0.92 |
chr3_97274804_97275284 | 4.15 |
Gm43073 |
predicted gene 43073 |
20 |
0.98 |
chr13_39440367_39440518 | 4.15 |
Gm47348 |
predicted gene, 47348 |
123 |
0.97 |
chr13_89584274_89585369 | 4.15 |
Hapln1 |
hyaluronan and proteoglycan link protein 1 |
310 |
0.91 |
chr9_71166294_71166626 | 4.11 |
Aqp9 |
aquaporin 9 |
1173 |
0.43 |
chr15_101235779_101236339 | 4.09 |
A330009N23Rik |
RIKEN cDNA A330009N23 gene |
10873 |
0.09 |
chr5_137919249_137919596 | 3.99 |
Cyp3a13 |
cytochrome P450, family 3, subfamily a, polypeptide 13 |
2197 |
0.14 |
chr6_52240578_52240985 | 3.89 |
Hoxa10 |
homeobox A10 |
14 |
0.91 |
chr1_130733959_130734110 | 3.88 |
AA986860 |
expressed sequence AA986860 |
1924 |
0.17 |
chr3_90537286_90538406 | 3.87 |
S100a16 |
S100 calcium binding protein A16 |
521 |
0.54 |
chr6_137570111_137570964 | 3.80 |
Eps8 |
epidermal growth factor receptor pathway substrate 8 |
222 |
0.95 |
chr17_83998890_83999228 | 3.72 |
8430430B14Rik |
RIKEN cDNA 8430430B14 gene |
505 |
0.69 |
chr11_88998963_89000826 | 3.72 |
Trim25 |
tripartite motif-containing 25 |
518 |
0.65 |
chr7_141079729_141081054 | 3.70 |
Pkp3 |
plakophilin 3 |
611 |
0.5 |
chr19_44749608_44751231 | 3.70 |
Pax2 |
paired box 2 |
5626 |
0.15 |
chr12_69783268_69783598 | 3.69 |
4930512B01Rik |
RIKEN cDNA 4930512B01 gene |
6855 |
0.13 |
chr16_44015370_44016774 | 3.68 |
Gramd1c |
GRAM domain containing 1C |
364 |
0.83 |
chr10_54070981_54071935 | 3.67 |
Man1a |
mannosidase 1, alpha |
4251 |
0.21 |
chr13_114271867_114272018 | 3.64 |
Gm47558 |
predicted gene, 47558 |
12439 |
0.19 |
chr7_19005590_19007911 | 3.62 |
Irf2bp1 |
interferon regulatory factor 2 binding protein 1 |
2706 |
0.11 |
chr2_158113366_158114213 | 3.60 |
Gm20412 |
predicted gene 20412 |
3365 |
0.19 |
chr8_121897389_121899362 | 3.57 |
Slc7a5 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 5 |
1873 |
0.2 |
chr2_4572310_4572962 | 3.53 |
Frmd4a |
FERM domain containing 4A |
6460 |
0.21 |
chr5_33104064_33104981 | 3.51 |
Slc5a1 |
solute carrier family 5 (sodium/glucose cotransporter), member 1 |
303 |
0.86 |
chr8_117334526_117335151 | 3.47 |
Cmip |
c-Maf inducing protein |
14332 |
0.24 |
chr11_60808665_60809149 | 3.41 |
Shmt1 |
serine hydroxymethyltransferase 1 (soluble) |
1886 |
0.16 |
chr6_116385480_116385958 | 3.38 |
Marchf8 |
membrane associated ring-CH-type finger 8 |
505 |
0.69 |
chr8_124499687_124499871 | 3.35 |
Cog2 |
component of oligomeric golgi complex 2 |
20988 |
0.17 |
chr19_10015065_10016667 | 3.35 |
Rab3il1 |
RAB3A interacting protein (rabin3)-like 1 |
822 |
0.48 |
chr14_27183522_27183673 | 3.33 |
Gm7591 |
predicted gene 7591 |
26800 |
0.18 |
chr2_128377708_128377954 | 3.31 |
Morrbid |
myeloid RNA regulator of BCL2L11 induced cell death |
25134 |
0.18 |
chr18_39485704_39487567 | 3.26 |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
597 |
0.82 |
chr10_89769073_89769465 | 3.26 |
Uhrf1bp1l |
UHRF1 (ICBP90) binding protein 1-like |
17931 |
0.18 |
chr5_50125758_50125972 | 3.25 |
4930448I18Rik |
RIKEN cDNA 4930448I18 gene |
25468 |
0.19 |
chr5_89223118_89223502 | 3.25 |
Slc4a4 |
solute carrier family 4 (anion exchanger), member 4 |
195218 |
0.03 |
chr6_87808783_87808991 | 3.21 |
Rab43 |
RAB43, member RAS oncogene family |
867 |
0.33 |
chr18_70643911_70644632 | 3.17 |
Gm8934 |
predicted gene 8934 |
3766 |
0.24 |
chr2_43555334_43556170 | 3.11 |
Kynu |
kynureninase |
398 |
0.9 |
chr8_35205176_35206377 | 3.09 |
Gm34474 |
predicted gene, 34474 |
12862 |
0.14 |
chr6_38919055_38920089 | 3.09 |
Tbxas1 |
thromboxane A synthase 1, platelet |
548 |
0.79 |
chr9_110689384_110689673 | 3.08 |
Gm35715 |
predicted gene, 35715 |
14574 |
0.1 |
chr4_49549075_49549386 | 3.05 |
Aldob |
aldolase B, fructose-bisphosphate |
316 |
0.86 |
chr11_96295460_96295999 | 3.05 |
Hoxb6 |
homeobox B6 |
3253 |
0.09 |
chr17_29928705_29929266 | 3.04 |
Gm16758 |
predicted gene, 16758 |
38901 |
0.1 |
chr6_55324306_55324538 | 3.01 |
Aqp1 |
aquaporin 1 |
12010 |
0.14 |
chr11_31896793_31897028 | 3.00 |
Cpeb4 |
cytoplasmic polyadenylation element binding protein 4 |
23635 |
0.18 |
chr11_78821748_78821939 | 2.99 |
Gm23219 |
predicted gene, 23219 |
2544 |
0.24 |
chr2_170344885_170345272 | 2.98 |
Bcas1 |
breast carcinoma amplified sequence 1 |
4662 |
0.21 |
chr19_57274847_57275476 | 2.95 |
4930449E18Rik |
RIKEN cDNA 4930449E18 gene |
1201 |
0.49 |
chr10_61544232_61544740 | 2.93 |
Gm47594 |
predicted gene, 47594 |
26425 |
0.1 |
chr17_86536044_86537023 | 2.92 |
Gm10309 |
predicted gene 10309 |
31301 |
0.19 |
chr9_32743344_32743495 | 2.92 |
Gm27240 |
predicted gene 27240 |
32248 |
0.15 |
chr5_30286170_30286752 | 2.91 |
Drc1 |
dynein regulatory complex subunit 1 |
5073 |
0.17 |
chr2_170173857_170174714 | 2.87 |
Zfp217 |
zinc finger protein 217 |
26182 |
0.23 |
chr2_115520165_115520316 | 2.85 |
3110099E03Rik |
RIKEN cDNA 3110099E03 gene |
7504 |
0.25 |
chr10_127204633_127204815 | 2.84 |
Pip4k2c |
phosphatidylinositol-5-phosphate 4-kinase, type II, gamma |
6831 |
0.08 |
chr17_13867197_13867901 | 2.84 |
Afdn |
afadin, adherens junction formation factor |
67 |
0.97 |
chr19_29743457_29744027 | 2.79 |
9930021J03Rik |
RIKEN cDNA 9930021J03 gene |
130 |
0.96 |
chr12_24889975_24890221 | 2.78 |
Mboat2 |
membrane bound O-acyltransferase domain containing 2 |
58467 |
0.09 |
chr18_64655477_64655628 | 2.76 |
Atp8b1 |
ATPase, class I, type 8B, member 1 |
5255 |
0.16 |
chr1_193423977_193424128 | 2.75 |
Gm38022 |
predicted gene, 38022 |
51238 |
0.09 |
chr14_70625458_70627688 | 2.74 |
Dmtn |
dematin actin binding protein |
418 |
0.75 |
chr18_64957284_64957554 | 2.74 |
Nedd4l |
neural precursor cell expressed, developmentally down-regulated gene 4-like |
19412 |
0.19 |
chr11_83850990_83852424 | 2.74 |
Hnf1b |
HNF1 homeobox B |
535 |
0.69 |
chr10_24628917_24629373 | 2.73 |
Gm15270 |
predicted gene 15270 |
32037 |
0.14 |
chr19_44991156_44991974 | 2.72 |
Sema4g |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G |
571 |
0.59 |
chr5_118488824_118489593 | 2.71 |
Gm15754 |
predicted gene 15754 |
2241 |
0.32 |
chr9_42463481_42463800 | 2.71 |
Tbcel |
tubulin folding cofactor E-like |
2179 |
0.28 |
chr19_45422176_45422501 | 2.66 |
Btrc |
beta-transducin repeat containing protein |
23128 |
0.15 |
chr3_129836696_129837785 | 2.64 |
Cfi |
complement component factor i |
503 |
0.7 |
chr3_94782908_94783870 | 2.62 |
Cgn |
cingulin |
3062 |
0.17 |
chr17_57061953_57062899 | 2.62 |
Crb3 |
crumbs family member 3 |
82 |
0.91 |
chr19_34251474_34251975 | 2.61 |
Acta2 |
actin, alpha 2, smooth muscle, aorta |
2506 |
0.24 |
chr11_90676738_90677124 | 2.61 |
Tom1l1 |
target of myb1-like 1 (chicken) |
10648 |
0.2 |
chr15_93594920_93596502 | 2.60 |
Prickle1 |
prickle planar cell polarity protein 1 |
180 |
0.97 |
chr8_83738506_83738670 | 2.60 |
Adgre5 |
adhesion G protein-coupled receptor E5 |
2581 |
0.17 |
chr15_13367621_13367832 | 2.59 |
Gm8238 |
predicted gene 8238 |
51130 |
0.16 |
chr8_80496570_80496939 | 2.57 |
Gypa |
glycophorin A |
2973 |
0.3 |
chr17_74458074_74459002 | 2.53 |
Nlrc4 |
NLR family, CARD domain containing 4 |
604 |
0.67 |
chr10_125328072_125328912 | 2.53 |
Slc16a7 |
solute carrier family 16 (monocarboxylic acid transporters), member 7 |
43 |
0.98 |
chr13_101763606_101764682 | 2.50 |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
4069 |
0.24 |
chr2_128715041_128715192 | 2.42 |
Mertk |
MER proto-oncogene tyrosine kinase |
16160 |
0.14 |
chr4_57282752_57282903 | 2.41 |
Gm12536 |
predicted gene 12536 |
17269 |
0.18 |
chr3_34485769_34486286 | 2.41 |
Gm29135 |
predicted gene 29135 |
3820 |
0.23 |
chr14_48570209_48570360 | 2.40 |
4930572G02Rik |
RIKEN cDNA 4930572G02 gene |
9477 |
0.12 |
chr2_65116603_65116964 | 2.38 |
Cobll1 |
Cobl-like 1 |
10924 |
0.26 |
chr14_74847376_74847726 | 2.36 |
Lrch1 |
leucine-rich repeats and calponin homology (CH) domain containing 1 |
37704 |
0.17 |
chr5_146974806_146975050 | 2.34 |
Mtif3 |
mitochondrial translational initiation factor 3 |
11128 |
0.17 |
chr7_31114363_31115023 | 2.33 |
Hpn |
hepsin |
582 |
0.56 |
chr4_87803538_87803927 | 2.32 |
Mllt3 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 |
2562 |
0.41 |
chr17_7927352_7927983 | 2.29 |
Tagap |
T cell activation Rho GTPase activating protein |
732 |
0.66 |
chr10_120873697_120874170 | 2.28 |
Msrb3 |
methionine sulfoxide reductase B3 |
2781 |
0.2 |
chr10_119075897_119076625 | 2.26 |
Gm18904 |
predicted gene, 18904 |
14081 |
0.14 |
chr4_139966062_139968036 | 2.24 |
Mir2139 |
microRNA 2139 |
571 |
0.58 |
chr13_3891572_3893506 | 2.22 |
Net1 |
neuroepithelial cell transforming gene 1 |
894 |
0.46 |
chr11_96173037_96173499 | 2.22 |
Gm11535 |
predicted gene 11535 |
4283 |
0.13 |
chr8_61713469_61713739 | 2.21 |
Palld |
palladin, cytoskeletal associated protein |
46485 |
0.17 |
chr5_31297265_31297798 | 2.16 |
Gckr |
glucokinase regulatory protein |
23 |
0.94 |
chr4_154499305_154500611 | 2.15 |
Prdm16 |
PR domain containing 16 |
28807 |
0.17 |
chr9_97344904_97345241 | 2.15 |
Gm15891 |
predicted gene 15891 |
4544 |
0.22 |
chr14_60134774_60134925 | 2.12 |
Gm6913 |
predicted gene 6913 |
6214 |
0.17 |
chr7_30493410_30493561 | 2.11 |
Prodh2 |
proline dehydrogenase (oxidase) 2 |
137 |
0.87 |
chr17_35131032_35132104 | 2.10 |
Apom |
apolipoprotein M |
482 |
0.44 |
chrX_10714381_10715702 | 2.10 |
Mid1ip1 |
Mid1 interacting protein 1 (gastrulation specific G12-like (zebrafish)) |
22 |
0.97 |
chr5_142440144_142441204 | 2.08 |
Ap5z1 |
adaptor-related protein complex 5, zeta 1 subunit |
23270 |
0.17 |
chr19_4068752_4068903 | 2.07 |
Gstp3 |
glutathione S-transferase pi 3 |
9258 |
0.06 |
chr4_53595789_53596025 | 2.06 |
Slc44a1 |
solute carrier family 44, member 1 |
198 |
0.94 |
chr7_71224092_71224526 | 2.04 |
6030442E23Rik |
RIKEN cDNA 6030442E23 gene |
7260 |
0.23 |
chr6_51178533_51179407 | 2.04 |
Mir148a |
microRNA 148a |
90940 |
0.08 |
chr8_68279205_68280180 | 2.03 |
Sh2d4a |
SH2 domain containing 4A |
2615 |
0.27 |
chr4_8237536_8238080 | 2.03 |
Car8 |
carbonic anhydrase 8 |
1233 |
0.46 |
chr12_76446447_76446724 | 2.02 |
Gm10451 |
predicted gene 10451 |
2025 |
0.21 |
chr1_75214392_75214921 | 2.02 |
Stk16 |
serine/threonine kinase 16 |
1595 |
0.14 |
chr2_58336757_58336908 | 2.01 |
Gm13545 |
predicted gene 13545 |
1515 |
0.42 |
chr17_57234322_57234473 | 2.00 |
C3 |
complement component 3 |
6261 |
0.11 |
chr15_81247657_81248208 | 2.00 |
8430426J06Rik |
RIKEN cDNA 8430426J06 gene |
36 |
0.97 |
chr9_42884724_42884990 | 1.99 |
Gm27509 |
predicted gene, 27509 |
22728 |
0.19 |
chr2_154631717_154631891 | 1.95 |
Gm14198 |
predicted gene 14198 |
832 |
0.46 |
chr17_44134755_44136009 | 1.94 |
Clic5 |
chloride intracellular channel 5 |
614 |
0.77 |
chr9_32239300_32239451 | 1.94 |
Arhgap32 |
Rho GTPase activating protein 32 |
5789 |
0.24 |
chr16_21818680_21818960 | 1.93 |
Map3k13 |
mitogen-activated protein kinase kinase kinase 13 |
7122 |
0.12 |
chr14_61645558_61645884 | 1.93 |
Dleu2 |
deleted in lymphocytic leukemia, 2 |
2901 |
0.12 |
chr3_37748060_37748266 | 1.91 |
Gm42921 |
predicted gene 42921 |
12874 |
0.11 |
chr8_128687067_128687592 | 1.91 |
Itgb1 |
integrin beta 1 (fibronectin receptor beta) |
1459 |
0.4 |
chr1_37495785_37496430 | 1.89 |
Mgat4a |
mannoside acetylglucosaminyltransferase 4, isoenzyme A |
12 |
0.97 |
chr15_37205636_37205787 | 1.88 |
Gm8664 |
predicted gene 8664 |
23010 |
0.12 |
chr2_75772696_75773126 | 1.88 |
Gm13657 |
predicted gene 13657 |
4277 |
0.17 |
chr1_10996026_10996299 | 1.88 |
Prex2 |
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 2 |
2644 |
0.36 |
chr5_66076928_66077290 | 1.87 |
Rbm47 |
RNA binding motif protein 47 |
3875 |
0.15 |
chr2_173742158_173742309 | 1.86 |
Vapb |
vesicle-associated membrane protein, associated protein B and C |
4722 |
0.17 |
chr6_99263557_99264940 | 1.85 |
Foxp1 |
forkhead box P1 |
2267 |
0.43 |
chr19_36808530_36809049 | 1.84 |
Gm50112 |
predicted gene, 50112 |
9859 |
0.2 |
chr5_147292277_147292672 | 1.83 |
Mir7k |
microRNA 7k |
9176 |
0.1 |
chr18_21298807_21300128 | 1.82 |
Garem1 |
GRB2 associated regulator of MAPK1 subtype 1 |
656 |
0.68 |
chr8_122286174_122287007 | 1.82 |
Zfpm1 |
zinc finger protein, multitype 1 |
4449 |
0.18 |
chr9_45850583_45851358 | 1.80 |
Bace1 |
beta-site APP cleaving enzyme 1 |
1753 |
0.19 |
chr5_88593717_88594080 | 1.79 |
Rufy3 |
RUN and FYVE domain containing 3 |
10104 |
0.16 |
chr3_106545478_106545703 | 1.78 |
Cept1 |
choline/ethanolaminephosphotransferase 1 |
1992 |
0.2 |
chr6_58640036_58641358 | 1.78 |
Abcg2 |
ATP binding cassette subfamily G member 2 (Junior blood group) |
115 |
0.97 |
chr2_79651150_79651635 | 1.78 |
Itprid2 |
ITPR interacting domain containing 2 |
12210 |
0.26 |
chr17_44136324_44136532 | 1.77 |
Clic5 |
chloride intracellular channel 5 |
1660 |
0.43 |
chr11_31888255_31888611 | 1.77 |
Cpeb4 |
cytoplasmic polyadenylation element binding protein 4 |
15158 |
0.2 |
chr6_48676737_48676890 | 1.76 |
Gimap9 |
GTPase, IMAP family member 9 |
684 |
0.43 |
chrX_75126679_75127283 | 1.75 |
Mpp1 |
membrane protein, palmitoylated |
3863 |
0.12 |
chr18_60377377_60377703 | 1.74 |
Iigp1 |
interferon inducible GTPase 1 |
1493 |
0.33 |
chr2_113845570_113845721 | 1.74 |
Arhgap11a |
Rho GTPase activating protein 11A |
2652 |
0.28 |
chr8_47652243_47652484 | 1.74 |
Gm8623 |
predicted gene 8623 |
19599 |
0.1 |
chr15_63710508_63710674 | 1.73 |
4930449C09Rik |
RIKEN cDNA 4930449C09 gene |
7227 |
0.14 |
chr1_52950885_52951416 | 1.72 |
1700019D03Rik |
RIKEN cDNA 1700019D03 gene |
1694 |
0.4 |
chr2_163643199_163643350 | 1.71 |
0610039K10Rik |
RIKEN cDNA 0610039K10 gene |
1576 |
0.25 |
chr7_101323407_101324183 | 1.70 |
Stard10 |
START domain containing 10 |
1824 |
0.19 |
chr4_58034392_58035124 | 1.67 |
Txndc8 |
thioredoxin domain containing 8 |
25634 |
0.22 |
chr10_18463109_18463816 | 1.65 |
Nhsl1 |
NHS-like 1 |
6426 |
0.26 |
chr11_20858897_20860237 | 1.64 |
Gm22807 |
predicted gene, 22807 |
11686 |
0.15 |
chr6_129449977_129450616 | 1.63 |
Clec1a |
C-type lectin domain family 1, member a |
1539 |
0.24 |
chr15_103242280_103243411 | 1.63 |
Hnrnpa1 |
heterogeneous nuclear ribonucleoprotein A1 |
2351 |
0.16 |
chr1_82641402_82641861 | 1.62 |
n-R5s213 |
nuclear encoded rRNA 5S 213 |
6618 |
0.18 |
chr13_30146582_30146883 | 1.61 |
Gm23206 |
predicted gene, 23206 |
1649 |
0.32 |
chr15_99862508_99862713 | 1.61 |
Lima1 |
LIM domain and actin binding 1 |
12061 |
0.08 |
chr12_84192576_84193882 | 1.60 |
Elmsan1 |
ELM2 and Myb/SANT-like domain containing 1 |
786 |
0.46 |
chr13_45455049_45455703 | 1.60 |
Gm47455 |
predicted gene, 47455 |
24374 |
0.17 |
chr6_90333325_90334527 | 1.60 |
Uroc1 |
urocanase domain containing 1 |
637 |
0.57 |
chr11_83852457_83853638 | 1.59 |
Hnf1b |
HNF1 homeobox B |
87 |
0.96 |
chr9_51312551_51312790 | 1.58 |
1810046K07Rik |
RIKEN cDNA 1810046K07 gene |
45 |
0.98 |
chr6_114012863_114013089 | 1.58 |
Gm15083 |
predicted gene 15083 |
8187 |
0.17 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 9.0 | GO:0035483 | gastric emptying(GO:0035483) |
1.7 | 5.1 | GO:0006562 | proline catabolic process(GO:0006562) |
1.2 | 3.6 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
1.2 | 3.6 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.0 | 4.0 | GO:0072039 | regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072039) negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072040) mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:1901145) regulation of somatic stem cell population maintenance(GO:1904672) negative regulation of somatic stem cell population maintenance(GO:1904673) |
0.9 | 2.6 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.8 | 2.5 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.8 | 2.5 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.8 | 3.0 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.7 | 2.8 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.7 | 1.3 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
0.6 | 2.9 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.6 | 5.1 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.6 | 2.8 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.5 | 8.9 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.5 | 4.7 | GO:0034063 | stress granule assembly(GO:0034063) |
0.5 | 1.8 | GO:0002159 | desmosome assembly(GO:0002159) |
0.4 | 2.6 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.4 | 1.1 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.4 | 1.8 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.3 | 1.4 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.3 | 1.7 | GO:0046618 | drug export(GO:0046618) |
0.3 | 1.0 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.3 | 1.4 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.3 | 2.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.3 | 2.0 | GO:0015871 | choline transport(GO:0015871) |
0.3 | 1.0 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.3 | 0.9 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
0.3 | 1.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.3 | 2.5 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.3 | 0.3 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.3 | 0.8 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.3 | 2.4 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.3 | 0.8 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.3 | 0.8 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.2 | 0.7 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.2 | 0.7 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.2 | 0.4 | GO:0071288 | glycerol transport(GO:0015793) cellular response to mercury ion(GO:0071288) |
0.2 | 2.6 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.2 | 0.6 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.2 | 0.6 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.2 | 1.0 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.2 | 0.6 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
0.2 | 1.7 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.2 | 0.6 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.2 | 0.9 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.2 | 1.1 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 0.4 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.2 | 0.5 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.2 | 3.5 | GO:0060065 | uterus development(GO:0060065) |
0.2 | 2.8 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.2 | 0.7 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.2 | 1.0 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.2 | 0.7 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.2 | 0.5 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.2 | 0.5 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.2 | 1.0 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.2 | 1.0 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.2 | 2.1 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 1.5 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.2 | 0.5 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.2 | 0.5 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.2 | 0.5 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.2 | 0.5 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.2 | 0.6 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.2 | 2.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.4 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.1 | 1.5 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.1 | 0.7 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.1 | 0.4 | GO:2000449 | regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.1 | 0.6 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.4 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.1 | 0.9 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.1 | 0.4 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 0.4 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
0.1 | 0.3 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.1 | 0.3 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.1 | 0.5 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.1 | 0.9 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.1 | 0.5 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.1 | 0.3 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
0.1 | 0.3 | GO:0036258 | multivesicular body assembly(GO:0036258) |
0.1 | 0.6 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.1 | 0.4 | GO:0043366 | beta selection(GO:0043366) |
0.1 | 0.4 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.1 | 5.4 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.1 | 0.2 | GO:0003166 | bundle of His development(GO:0003166) |
0.1 | 0.1 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.1 | 1.2 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 2.7 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.3 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 0.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.1 | 0.2 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.5 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 4.5 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.1 | 1.7 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.1 | 1.7 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.1 | 0.3 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.1 | 0.8 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.3 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.1 | 0.4 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.1 | 0.2 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.1 | 1.6 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.1 | 0.2 | GO:0035799 | ureter maturation(GO:0035799) |
0.1 | 0.2 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 0.4 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.1 | 0.7 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.1 | 1.0 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.1 | 0.3 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.1 | 0.6 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.1 | 2.3 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 0.3 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 0.3 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.1 | 0.5 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.1 | 0.9 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.1 | 0.3 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.1 | 0.5 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.2 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.1 | 1.4 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 0.4 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.1 | 0.7 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.1 | 0.6 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.1 | 0.4 | GO:0030578 | PML body organization(GO:0030578) |
0.1 | 3.4 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 0.2 | GO:0002432 | granuloma formation(GO:0002432) |
0.1 | 0.6 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 0.3 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.4 | GO:0009597 | detection of virus(GO:0009597) |
0.1 | 0.8 | GO:0007379 | segment specification(GO:0007379) |
0.1 | 0.2 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 | 5.5 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
0.1 | 0.2 | GO:0044849 | estrous cycle(GO:0044849) |
0.1 | 0.3 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.1 | 0.3 | GO:0060068 | vagina development(GO:0060068) |
0.1 | 0.2 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.1 | 0.3 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.2 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.1 | 0.6 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.3 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 0.2 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.1 | 0.5 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.1 | 0.2 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.1 | 0.8 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.2 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.1 | 0.2 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.1 | 0.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 0.2 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 0.2 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.1 | 0.4 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.5 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.3 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 0.3 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.1 | 1.6 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.2 | GO:0044838 | cell quiescence(GO:0044838) |
0.1 | 0.6 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 0.2 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.1 | 0.2 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 1.0 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.2 | GO:0040031 | snRNA modification(GO:0040031) |
0.1 | 0.3 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.1 | 0.6 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.1 | 0.6 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.1 | 0.1 | GO:0016237 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.1 | 0.1 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.1 | 0.2 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.1 | 0.1 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.1 | 0.1 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.1 | 0.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.1 | 1.9 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 0.1 | GO:0072038 | mesenchymal stem cell maintenance involved in nephron morphogenesis(GO:0072038) |
0.1 | 0.5 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 0.5 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.1 | 0.1 | GO:0070662 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.1 | 0.1 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.1 | 0.1 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 0.1 | GO:0097503 | sialylation(GO:0097503) |
0.1 | 0.5 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.3 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 1.4 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
0.1 | 0.2 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.1 | 0.1 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.1 | 0.3 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.1 | 0.3 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.1 | 0.4 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.1 | 0.4 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 0.1 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.1 | 0.1 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.1 | 0.4 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.1 | 0.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 0.4 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.2 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.1 | 0.1 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.1 | 0.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.9 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 1.5 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.1 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
0.1 | 0.3 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 0.3 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.1 | 0.1 | GO:0007494 | midgut development(GO:0007494) |
0.1 | 0.1 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.1 | 0.2 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.0 | 0.1 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.0 | 0.1 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.0 | 4.3 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.0 | 0.1 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.0 | 0.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.2 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.2 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.1 | GO:0072203 | cell proliferation involved in metanephros development(GO:0072203) |
0.0 | 0.0 | GO:0043622 | cortical microtubule organization(GO:0043622) |
0.0 | 0.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.0 | 0.0 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.0 | 0.6 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.0 | 0.5 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.0 | 0.0 | GO:0042701 | progesterone secretion(GO:0042701) |
0.0 | 0.3 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.0 | 1.0 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 0.0 | GO:1903278 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
0.0 | 0.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.0 | 0.4 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.0 | 0.2 | GO:0044351 | macropinocytosis(GO:0044351) |
0.0 | 0.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.1 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.0 | 0.2 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.0 | 0.1 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.0 | 0.0 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.0 | 0.2 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.1 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.0 | 0.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.5 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.0 | 0.2 | GO:0070842 | aggresome assembly(GO:0070842) |
0.0 | 0.2 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.2 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.0 | 0.1 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.0 | 0.1 | GO:0032439 | endosome localization(GO:0032439) |
0.0 | 0.1 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.0 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.0 | 0.8 | GO:0015893 | drug transport(GO:0015893) |
0.0 | 0.2 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.0 | 0.1 | GO:1904124 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.0 | 0.1 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.0 | 0.0 | GO:1901536 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.0 | 0.2 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.0 | 0.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.0 | 0.1 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.0 | 0.1 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.0 | 0.1 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.0 | 0.4 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.0 | 0.1 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.0 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.1 | GO:0061450 | trophoblast cell migration(GO:0061450) |
0.0 | 0.1 | GO:0090009 | primitive streak formation(GO:0090009) |
0.0 | 1.0 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.4 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.0 | 0.3 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.1 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.0 | 0.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.1 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.0 | 0.6 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.0 | 0.1 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) |
0.0 | 0.1 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.0 | 0.1 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.0 | 0.3 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.0 | 0.1 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.2 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 0.1 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.0 | 0.7 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
0.0 | 0.1 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.0 | 0.1 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.0 | 0.2 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.0 | 0.3 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.0 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.1 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.0 | 0.0 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.0 | 0.1 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.1 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.0 | 0.3 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.0 | 0.0 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.0 | 0.1 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.0 | 0.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.1 | GO:0071671 | regulation of smooth muscle cell chemotaxis(GO:0071671) negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
0.0 | 0.1 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.0 | 0.1 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.0 | 0.0 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.0 | 0.1 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.0 | 0.5 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.0 | 0.2 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.0 | 0.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.0 | 0.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.0 | 0.1 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.0 | 0.0 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
0.0 | 0.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.0 | 0.1 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.0 | 0.2 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.0 | 0.0 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.0 | 0.1 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.0 | 0.1 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.0 | 0.0 | GO:0035482 | gastric motility(GO:0035482) |
0.0 | 0.0 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.0 | 0.1 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.0 | 0.0 | GO:0006808 | regulation of nitrogen utilization(GO:0006808) |
0.0 | 0.1 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.0 | 3.0 | GO:0098780 | mitophagy in response to mitochondrial depolarization(GO:0098779) response to mitochondrial depolarisation(GO:0098780) |
0.0 | 0.1 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.0 | 0.1 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.0 | 0.0 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.0 | 0.4 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.0 | 0.1 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.0 | 0.1 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.0 | 0.1 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.0 | 0.8 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.0 | 0.1 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.0 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.1 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.0 | 0.1 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.0 | 0.7 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 1.1 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.0 | 0.0 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.0 | 0.1 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.0 | 0.6 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.0 | 0.1 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.0 | 0.1 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.0 | 0.3 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.1 | GO:0002585 | positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) |
0.0 | 0.1 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.0 | 0.2 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.2 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.0 | 0.2 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.0 | 0.1 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 0.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 0.1 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.0 | 0.1 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.1 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.0 | 0.0 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.0 | 0.1 | GO:0001553 | luteinization(GO:0001553) |
0.0 | 0.0 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.0 | 0.0 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.0 | 0.1 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.0 | 0.5 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) |
0.0 | 0.1 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.0 | 0.1 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.0 | 0.3 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 0.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.4 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.0 | 0.4 | GO:0006301 | postreplication repair(GO:0006301) |
0.0 | 0.1 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.0 | 0.0 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.0 | 0.0 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.0 | 0.1 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.0 | 0.0 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.0 | 3.6 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.3 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.1 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.0 | 0.0 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.0 | 0.2 | GO:0080111 | DNA demethylation(GO:0080111) |
0.0 | 0.3 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.0 | 0.2 | GO:0030728 | ovulation(GO:0030728) |
0.0 | 0.0 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.0 | 0.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.2 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.5 | GO:0048536 | spleen development(GO:0048536) |
0.0 | 0.1 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.0 | 0.3 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.1 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.0 | 0.1 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.0 | 0.2 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.2 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.3 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.0 | 0.1 | GO:0045628 | regulation of T-helper 2 cell differentiation(GO:0045628) negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.0 | 0.0 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.0 | 0.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.0 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.1 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.0 | 0.1 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.0 | 0.0 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.0 | 0.1 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.0 | 0.2 | GO:0097286 | iron ion import(GO:0097286) |
0.0 | 0.0 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.0 | 0.7 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.0 | 0.1 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.0 | 0.3 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.0 | 0.1 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.0 | 0.0 | GO:0036394 | amylase secretion(GO:0036394) |
0.0 | 0.2 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.0 | 0.3 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.0 | 0.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.0 | 0.3 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.1 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.0 | 0.1 | GO:0035561 | regulation of chromatin binding(GO:0035561) |
0.0 | 0.2 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.0 | 0.0 | GO:0072683 | T cell extravasation(GO:0072683) |
0.0 | 0.0 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.0 | 0.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.0 | 0.1 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.0 | 0.0 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.0 | 0.1 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.0 | 0.0 | GO:0051938 | L-glutamate import(GO:0051938) L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.3 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.1 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.0 | 0.0 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.0 | 0.0 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.0 | 0.2 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.0 | 0.1 | GO:0097049 | motor neuron apoptotic process(GO:0097049) regulation of motor neuron apoptotic process(GO:2000671) |
0.0 | 0.7 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.0 | 0.0 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.0 | 0.0 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
0.0 | 0.0 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.0 | 0.0 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.0 | 0.4 | GO:0043631 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.0 | 0.2 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.0 | 0.1 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.0 | 0.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.1 | GO:0030220 | platelet formation(GO:0030220) |
0.0 | 0.0 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.0 | 0.3 | GO:0030201 | heparan sulfate proteoglycan metabolic process(GO:0030201) |
0.0 | 0.1 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.0 | 0.2 | GO:0071622 | regulation of granulocyte chemotaxis(GO:0071622) |
0.0 | 0.1 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.0 | 1.0 | GO:0051592 | response to calcium ion(GO:0051592) |
0.0 | 0.1 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 0.0 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.0 | 0.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.0 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.0 | 0.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.0 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.0 | 0.3 | GO:0070527 | platelet aggregation(GO:0070527) |
0.0 | 0.2 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 0.0 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.0 | 0.2 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.0 | 0.0 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.0 | 0.0 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.0 | 0.2 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.0 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.0 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.0 | 0.1 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.0 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.0 | 0.3 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.0 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.0 | 0.1 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.1 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.0 | GO:1904395 | positive regulation of postsynaptic membrane organization(GO:1901628) positive regulation of receptor clustering(GO:1903911) regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.0 | 0.1 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.0 | 0.1 | GO:0010957 | negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.0 | 0.0 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.0 | 0.2 | GO:0044062 | regulation of excretion(GO:0044062) |
0.0 | 0.1 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.0 | 0.0 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.0 | 0.1 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.0 | 0.1 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.0 | 0.1 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.0 | 0.2 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.0 | 0.1 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.0 | 0.6 | GO:0007569 | cell aging(GO:0007569) |
0.0 | 0.2 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.3 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.4 | GO:0070206 | protein trimerization(GO:0070206) |
0.0 | 0.1 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.0 | 0.1 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.0 | 0.0 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.0 | 0.0 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.0 | 0.2 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.0 | 0.1 | GO:0045002 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.0 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.0 | 0.2 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.0 | 0.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.0 | 0.0 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.0 | 0.1 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) |
0.0 | 0.0 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.0 | 0.1 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.0 | 0.1 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 0.1 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.0 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.0 | 0.0 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.0 | 0.2 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.0 | 0.1 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.0 | 0.0 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.0 | 0.1 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.0 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.0 | 0.3 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.0 | 0.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.6 | GO:0030203 | glycosaminoglycan metabolic process(GO:0030203) |
0.0 | 0.1 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.5 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
0.0 | 0.0 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.0 | 0.0 | GO:0006586 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.0 | 0.1 | GO:0018904 | ether metabolic process(GO:0018904) |
0.0 | 0.1 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.0 | 0.0 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.0 | 0.0 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.0 | 0.2 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.1 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.0 | 0.1 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.1 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.0 | 0.1 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.0 | 0.0 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.0 | 0.1 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.0 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.0 | 0.0 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.0 | 0.1 | GO:0046836 | glycolipid transport(GO:0046836) |
0.0 | 0.1 | GO:0000338 | protein deneddylation(GO:0000338) |
0.0 | 0.0 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.0 | 0.1 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 0.0 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.0 | 0.0 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.0 | 0.0 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.0 | 0.0 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.0 | 0.0 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.0 | 0.0 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.0 | 0.0 | GO:0015840 | urea transport(GO:0015840) |
0.0 | 0.0 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.0 | 0.1 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.0 | 0.0 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.0 | 0.0 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.0 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.0 | 0.1 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.0 | 0.0 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.0 | 0.3 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.0 | 0.0 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.0 | 0.0 | GO:0061055 | myotome development(GO:0061055) |
0.0 | 0.0 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.0 | 0.1 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.0 | 0.4 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.1 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.6 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.6 | 1.8 | GO:0005914 | spot adherens junction(GO:0005914) |
0.4 | 2.1 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.3 | 0.9 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.3 | 0.9 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.3 | 1.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.3 | 1.7 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.3 | 3.1 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.2 | 0.9 | GO:0030689 | Noc complex(GO:0030689) |
0.2 | 1.3 | GO:0005688 | U6 snRNP(GO:0005688) |
0.2 | 0.5 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.4 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.1 | 4.8 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 1.1 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 0.7 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 0.6 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 0.4 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.5 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.1 | 0.7 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 0.5 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 0.2 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 0.4 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 0.6 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.1 | 5.0 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 0.2 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.1 | 1.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 10.8 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.3 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.1 | 0.4 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.1 | 0.2 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.1 | 0.3 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.1 | 0.2 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 0.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 2.9 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 0.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 0.4 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 0.2 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 0.2 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.1 | 0.3 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 0.6 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.3 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.5 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 0.2 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 0.2 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 1.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.0 | 0.3 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.0 | 0.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 0.7 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 0.2 | GO:0043219 | lateral loop(GO:0043219) |
0.0 | 0.2 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.3 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.0 | 0.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.0 | 0.0 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.0 | 9.0 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 0.2 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.0 | 0.3 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 0.9 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.7 | GO:0045120 | pronucleus(GO:0045120) |
0.0 | 0.2 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.0 | 0.2 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.0 | 2.8 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.4 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.3 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 0.1 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.0 | 0.1 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.0 | 0.1 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.0 | 0.4 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.1 | GO:1990696 | USH2 complex(GO:1990696) |
0.0 | 1.1 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 0.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.2 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.0 | 0.9 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 1.7 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 1.1 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 0.3 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 0.9 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.0 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 0.6 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 0.0 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 0.5 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.3 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 2.5 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 0.1 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.2 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.1 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.0 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 0.3 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.3 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.0 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.0 | 0.1 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 0.4 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.3 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.0 | 0.1 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 4.8 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.3 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.0 | 0.2 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.1 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) lumenal side of membrane(GO:0098576) |
0.0 | 0.0 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.0 | 0.0 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.2 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 2.0 | GO:0043197 | dendritic spine(GO:0043197) |
0.0 | 0.1 | GO:1990462 | omegasome(GO:1990462) |
0.0 | 0.1 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.0 | 0.0 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.0 | 1.2 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 1.1 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.0 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.0 | 0.2 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.0 | 0.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 0.7 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.4 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.1 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 0.1 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.8 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.0 | 0.4 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 5.7 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.0 | 2.0 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.1 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 0.3 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.2 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 5.3 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 0.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.2 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.1 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.1 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.0 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.0 | 0.1 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 0.1 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 0.0 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.0 | 0.5 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.1 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 0.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.5 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.1 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.1 | GO:0002102 | podosome(GO:0002102) |
0.0 | 28.3 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 0.0 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.0 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.0 | 0.0 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.3 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 17.3 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.0 | GO:0005683 | U7 snRNP(GO:0005683) |
0.0 | 0.1 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.0 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.0 | 0.6 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 0.0 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.0 | 0.1 | GO:0097342 | ripoptosome(GO:0097342) |
0.0 | 0.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.0 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.0 | 0.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.0 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 8.7 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.9 | 2.8 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.8 | 2.5 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.7 | 3.4 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.7 | 2.6 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.6 | 3.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.6 | 1.8 | GO:0005350 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.6 | 2.9 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.5 | 6.1 | GO:0019176 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
0.5 | 1.9 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.4 | 2.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.4 | 1.9 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.3 | 2.4 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.3 | 1.0 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.3 | 0.9 | GO:0035877 | death effector domain binding(GO:0035877) |
0.3 | 1.7 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.3 | 0.8 | GO:0051870 | methotrexate binding(GO:0051870) |
0.3 | 0.8 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.3 | 2.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.3 | 6.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 0.8 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.3 | 4.8 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.2 | 0.7 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.2 | 0.7 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.2 | 1.3 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.2 | 1.4 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.2 | 0.6 | GO:0043199 | sulfate binding(GO:0043199) |
0.2 | 1.7 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.2 | 4.9 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.2 | 0.9 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.2 | 0.5 | GO:0030172 | troponin C binding(GO:0030172) |
0.2 | 0.5 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.2 | 0.5 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.2 | 0.7 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.2 | 0.5 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.2 | 0.6 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.1 | 3.1 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.1 | 0.6 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.1 | 0.5 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 3.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 5.3 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.4 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.1 | 0.7 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 0.8 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 2.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.7 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 1.6 | GO:0035173 | histone kinase activity(GO:0035173) |
0.1 | 2.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 1.2 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.2 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 1.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.8 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 1.2 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.9 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.9 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.1 | 0.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.3 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.1 | 1.8 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.1 | 0.4 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 1.5 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 0.3 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.1 | 0.3 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 0.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.1 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.1 | 0.7 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.1 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.1 | 0.1 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.1 | 0.4 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.1 | 7.7 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.3 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.2 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.1 | 0.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.2 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 0.3 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.2 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.1 | 0.5 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 0.4 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.1 | 0.3 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.1 | 0.5 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.1 | 0.4 | GO:0098631 | protein binding involved in cell adhesion(GO:0098631) |
0.1 | 0.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 0.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.6 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.1 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 1.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 3.1 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.1 | 0.3 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 5.8 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 1.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.4 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.1 | 0.4 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.3 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.1 | 0.9 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.2 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 0.7 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.8 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.2 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.1 | 0.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.2 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.2 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 0.2 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.3 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 0.1 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.1 | 0.2 | GO:0034548 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.1 | 1.9 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.2 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 0.4 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.2 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.2 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 0.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.1 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.0 | 0.4 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.7 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.9 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.0 | 4.1 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 0.4 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 3.5 | GO:0005254 | chloride channel activity(GO:0005254) |
0.0 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.7 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.0 | 0.3 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.1 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.0 | 0.5 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 1.2 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.0 | 0.3 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.1 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.0 | 0.1 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 2.0 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 0.6 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.1 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.0 | 0.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.0 | 0.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.3 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 0.0 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.3 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.0 | 0.2 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.6 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.5 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.0 | 0.8 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.3 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.0 | 0.3 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.0 | 0.2 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.4 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 0.1 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.8 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 0.3 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 0.7 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 5.6 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.0 | 0.2 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.1 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 0.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.1 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.0 | 1.0 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 0.8 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 5.8 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.9 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 0.1 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.0 | 0.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.1 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 0.1 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.0 | 0.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 0.9 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 0.1 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.0 | GO:0097001 | ceramide binding(GO:0097001) |
0.0 | 0.2 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.0 | 0.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.0 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.0 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.3 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 0.1 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.0 | 0.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.0 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.0 | 1.0 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.0 | 0.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.1 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.0 | 0.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 3.8 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.1 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.0 | 0.1 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.0 | 0.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.0 | 0.0 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.0 | 0.4 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.1 | GO:0034951 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.0 | 0.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.0 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.7 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.0 | 0.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 0.2 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.1 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.0 | 0.2 | GO:0018857 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.0 | 0.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.4 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.0 | 0.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 0.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.1 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.1 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.0 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.5 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
0.0 | 0.2 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.6 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 3.4 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.0 | 0.1 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 0.2 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.0 | 0.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.1 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.0 | 0.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.0 | 0.2 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.1 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.7 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.0 | 0.2 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.0 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.0 | 9.8 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.1 | GO:0034891 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.0 | 0.1 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.0 | GO:0030351 | inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity(GO:0030351) inositol-1,4,5,6-tetrakisphosphate 6-phosphatase activity(GO:0030352) inositol pentakisphosphate phosphatase activity(GO:0052827) |
0.0 | 0.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.0 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.0 | 0.2 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.0 | 0.1 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 0.1 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.0 | 0.3 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.1 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 0.1 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.1 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.2 | GO:0016594 | glycine binding(GO:0016594) |
0.0 | 0.2 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.9 | GO:0005319 | lipid transporter activity(GO:0005319) |
0.0 | 0.8 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.1 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.0 | 0.7 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 1.2 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.0 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.0 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.0 | 0.0 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.0 | 0.0 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.0 | 0.2 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.3 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.0 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.0 | 0.0 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.8 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 0.0 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.1 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.0 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.0 | 0.0 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.0 | 0.5 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.0 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 0.0 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.0 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 0.1 | GO:0018748 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.0 | 0.2 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 1.0 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 0.1 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.0 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.0 | 0.0 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 1.6 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.0 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.0 | 0.2 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.0 | 0.0 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.0 | 0.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.1 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 0.0 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 0.0 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.0 | 1.4 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.0 | 0.0 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.0 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.0 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.0 | 0.1 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.0 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.0 | 0.0 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.1 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.0 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.0 | 0.4 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.0 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.0 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.0 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.0 | 0.0 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.0 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.0 | 0.0 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.3 | 11.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 8.8 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 1.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 3.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 1.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 4.6 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 2.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 3.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 3.5 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 0.5 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 0.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 0.5 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 0.4 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 0.5 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.3 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.9 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 2.2 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.9 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 1.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.4 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 1.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.4 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.7 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 0.6 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 5.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 1.0 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.6 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.7 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.7 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.5 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.7 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.5 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.8 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.2 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.2 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.3 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.2 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.0 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 0.1 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.0 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.4 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 6.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.3 | 2.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.3 | 3.4 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.2 | 1.9 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 2.6 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 2.1 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 1.9 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 0.5 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 4.4 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 1.0 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.1 | 2.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 2.0 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 2.0 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 1.3 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 2.3 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 3.0 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 1.7 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 3.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 1.4 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 3.1 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 1.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 0.9 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 0.4 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 1.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 0.9 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 1.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 0.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 2.1 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.1 | 2.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 0.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 0.9 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 0.2 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 1.8 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 0.4 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.1 | 1.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 2.3 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 1.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 3.1 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.1 | 5.1 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 1.6 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.6 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 0.5 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 0.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.9 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 1.9 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 11.0 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 0.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.2 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.0 | 0.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 1.0 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.3 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.9 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.0 | 0.4 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 1.1 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.4 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 0.3 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.4 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.0 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.0 | 0.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.4 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.0 | 0.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 1.2 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.4 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.9 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.6 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 1.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.1 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.2 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.3 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.1 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.0 | 0.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 1.3 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.0 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.3 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.0 | 0.0 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.0 | 0.1 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.1 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 0.4 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.0 | 0.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.1 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.0 | 0.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.2 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.2 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.4 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.9 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.1 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.0 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.0 | 0.2 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.1 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 0.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.6 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |